Showing 34,667 results

New & experimental hepatitis C treatment

Abbott Announces Phase 3 Interferon-free Hepatitis C Regimens to be Studied in Broad Patient Populations

Editor's pick
Abbott press release
14 November 2012

Man held over death of delegate at international conference

Editor's pick
Daily Express
14 November 2012
New & experimental hepatitis C treatment

94% response rate to HCV treatment without ribavirin or interferon in harder-to-treat

News
13 November 2012
HIV prevention policy

LA County's Measure B is a major win for safe sex in adult entertainment

Editor's pick
The Guardian
13 November 2012
Pregnancy and vertical transmission

South Africa: Challenges of Breast-Feeding

Editor's pick
AllAfrica
13 November 2012
Government, leadership & policy

Uganda: We Must Scale Up the Fight - New Taso Boss

Editor's pick
AllAfrica
13 November 2012
Epidemiology & behaviour

Rwanda: HIV Infection At 51 Percent Among Sex Workers

Editor's pick
AllAfrica
13 November 2012
Hepatitis C treatment side-effects

Reducing ribavirin and adding EPO are both good anaemia management strategies for people taking boceprevir

News
13 November 2012
Experiences of stigma

SWAZILAND: HIV stigma still a barrier

Editor's pick
IRIN Plus News
13 November 2012

SWAZILAND: HIV stigma still a barrier

Editor's pick
IRIN
13 November 2012
Global health initiatives

Next Global Fund director to be chosen from four candidates this week

Editor's pick
EATG / Intellectual Property Watch
13 November 2012
Changing treatment

Raltegravir-resistant HIV stays susceptible to dolutegravir in lab

Editor's pick
International AIDS Society
13 November 2012
Hepatitis C symptoms & diagnosis

Background liver proliferation linked to noncirrhotic HCC in patients with HCV

Editor's pick
Healio Hepatology
13 November 2012
New & experimental hepatitis C treatment

Achillion Provides Update on Clinical HCV Development Programs

Editor's pick
Achillion press release
13 November 2012
New & experimental hepatitis C treatment

Hep C Competitors Cede Space To Gilead And Bristol-Myers And Turn To Niche Uses

Editor's pick
Seeking Alpha
13 November 2012
New & experimental hepatitis C treatment

Gilead Climbs on Study Results of Hepatitis C Combination

Editor's pick
Bloomberg
12 November 2012
New & experimental hepatitis C treatment

Novartis' Certican succeeds in liver transplant trial

Editor's pick
Reuters
12 November 2012
New & experimental hepatitis C treatment

AASLD-GI-5005 Improves Virologic Clearance of HCV in Combination with PegIFN/Ribavirin in IL28B T/T Patients

Editor's pick
HCV New Drugs Research
12 November 2012
New & experimental hepatitis C treatment

Abbott interferon-free combination 'promising' in harder-to-treat patients with hepatitis C

News
12 November 2012
Men who have sex with men (MSM)

Report: Uganda’s Speaker Promises To Pass Anti-Homosexuality Bill in Two Weeks

Editor's pick
Box Turtle Bulletin
12 November 2012
New & experimental hepatitis C treatment

High rate of response to BMS HCV drugs in harder-to-treat patients – but interferon-free prospects differ by sub-genotype

News
12 November 2012
New & experimental hepatitis C treatment

Final study results show telaprevir is safe and effective for HIV/HCV co-infected people

News
12 November 2012

"Mild growth" in private US, EU funding for HIV

Editor's pick
IRIN
12 November 2012
Finance & funding

"Mild growth" in private US, EU funding for HIV

Editor's pick
IRIN Plus News
12 November 2012